Cargando…

Oncotherapeutic Strategies in Early Onset Colorectal Cancer

SIMPLE SUMMARY: Early onset colorectal cancer (defined as colorectal cancer in those less than 50 years of age) is increasing in incidence worldwide. There are many risk factors for the development of early-onset colorectal cancer, including genetic predisposition syndromes, the disruption of gut mi...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Reilly, Mary, Linehan, Anna, Krstic, Aleksandar, Kolch, Walter, Sheahan, Kieran, Winter, Des C., Mc Dermott, Ray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856676/
https://www.ncbi.nlm.nih.gov/pubmed/36672501
http://dx.doi.org/10.3390/cancers15020552
_version_ 1784873691688992768
author O’Reilly, Mary
Linehan, Anna
Krstic, Aleksandar
Kolch, Walter
Sheahan, Kieran
Winter, Des C.
Mc Dermott, Ray
author_facet O’Reilly, Mary
Linehan, Anna
Krstic, Aleksandar
Kolch, Walter
Sheahan, Kieran
Winter, Des C.
Mc Dermott, Ray
author_sort O’Reilly, Mary
collection PubMed
description SIMPLE SUMMARY: Early onset colorectal cancer (defined as colorectal cancer in those less than 50 years of age) is increasing in incidence worldwide. There are many risk factors for the development of early-onset colorectal cancer, including genetic predisposition syndromes, the disruption of gut microbiota, obesity, and inflammatory bowel disease. Due to a lack of awareness of this condition in both the medical and general community, there is often a delay in reaching this diagnosis; this leads to worse outcomes than are present among their older counterparts. This is a cohort with specific physical, emotional, social, and financial needs. The aim of this review is to discuss the etiology and treatment strategies for this patient group. ABSTRACT: Early onset colorectal cancer (EOCRC), defined as colorectal cancers in patients aged less than 50 years, is becoming an increasingly common issue, globally. Since 1994, the incidence of this condition has been rising by 2% annually. Approximately one in five patients under 50 years of age diagnosed with colorectal cancer have an underlying genetic predisposition syndrome. The detection of cancer among the other 80% of patients poses a considerable task, as there is no family history to advocate for commencing early screening in this group. Patients with EOCRC have distinct social, spiritual, fertility, and financial needs from their older counterparts that need to be addressed. This review discusses the risk factors associated with the development of EOCRC and current best practice for the management of this disease.
format Online
Article
Text
id pubmed-9856676
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98566762023-01-21 Oncotherapeutic Strategies in Early Onset Colorectal Cancer O’Reilly, Mary Linehan, Anna Krstic, Aleksandar Kolch, Walter Sheahan, Kieran Winter, Des C. Mc Dermott, Ray Cancers (Basel) Review SIMPLE SUMMARY: Early onset colorectal cancer (defined as colorectal cancer in those less than 50 years of age) is increasing in incidence worldwide. There are many risk factors for the development of early-onset colorectal cancer, including genetic predisposition syndromes, the disruption of gut microbiota, obesity, and inflammatory bowel disease. Due to a lack of awareness of this condition in both the medical and general community, there is often a delay in reaching this diagnosis; this leads to worse outcomes than are present among their older counterparts. This is a cohort with specific physical, emotional, social, and financial needs. The aim of this review is to discuss the etiology and treatment strategies for this patient group. ABSTRACT: Early onset colorectal cancer (EOCRC), defined as colorectal cancers in patients aged less than 50 years, is becoming an increasingly common issue, globally. Since 1994, the incidence of this condition has been rising by 2% annually. Approximately one in five patients under 50 years of age diagnosed with colorectal cancer have an underlying genetic predisposition syndrome. The detection of cancer among the other 80% of patients poses a considerable task, as there is no family history to advocate for commencing early screening in this group. Patients with EOCRC have distinct social, spiritual, fertility, and financial needs from their older counterparts that need to be addressed. This review discusses the risk factors associated with the development of EOCRC and current best practice for the management of this disease. MDPI 2023-01-16 /pmc/articles/PMC9856676/ /pubmed/36672501 http://dx.doi.org/10.3390/cancers15020552 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
O’Reilly, Mary
Linehan, Anna
Krstic, Aleksandar
Kolch, Walter
Sheahan, Kieran
Winter, Des C.
Mc Dermott, Ray
Oncotherapeutic Strategies in Early Onset Colorectal Cancer
title Oncotherapeutic Strategies in Early Onset Colorectal Cancer
title_full Oncotherapeutic Strategies in Early Onset Colorectal Cancer
title_fullStr Oncotherapeutic Strategies in Early Onset Colorectal Cancer
title_full_unstemmed Oncotherapeutic Strategies in Early Onset Colorectal Cancer
title_short Oncotherapeutic Strategies in Early Onset Colorectal Cancer
title_sort oncotherapeutic strategies in early onset colorectal cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856676/
https://www.ncbi.nlm.nih.gov/pubmed/36672501
http://dx.doi.org/10.3390/cancers15020552
work_keys_str_mv AT oreillymary oncotherapeuticstrategiesinearlyonsetcolorectalcancer
AT linehananna oncotherapeuticstrategiesinearlyonsetcolorectalcancer
AT krsticaleksandar oncotherapeuticstrategiesinearlyonsetcolorectalcancer
AT kolchwalter oncotherapeuticstrategiesinearlyonsetcolorectalcancer
AT sheahankieran oncotherapeuticstrategiesinearlyonsetcolorectalcancer
AT winterdesc oncotherapeuticstrategiesinearlyonsetcolorectalcancer
AT mcdermottray oncotherapeuticstrategiesinearlyonsetcolorectalcancer